Elucidating the exact pharmacological mechanism of action (MOA) of Obviously developing compounds could be demanding. While Tarselli et al. (60) designed the very first de novo artificial pathway to conolidine and showcased this naturally developing compound correctly suppresses responses to each chemically induced and inflammation-derived ache, th